These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 18727662)
1. Hepatocellular carcinoma metastatic to skin: diagnostic utility of antihuman hepatocyte antibody in combination with albumin in situ hybridization. Wood AJ; Lappinga PJ; Ahmed I J Cutan Pathol; 2009 Feb; 36(2):262-6. PubMed ID: 18727662 [TBL] [Abstract][Full Text] [Related]
2. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma]. Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075 [TBL] [Abstract][Full Text] [Related]
3. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors. Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880 [TBL] [Abstract][Full Text] [Related]
4. Albumin gene expression in liver tumors: diagnostic interest in fine needle aspiration biopsies. Papotti M; Pacchioni D; Negro F; Bonino F; Bussolati G Mod Pathol; 1994 Apr; 7(3):271-5. PubMed ID: 8058698 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Pitman MB; Triratanachat S; Young RH; Oliva E Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552 [TBL] [Abstract][Full Text] [Related]
6. Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1. Sugiki T; Yamamoto M; Aruga A; Takasaki K; Nakano M J Surg Oncol; 2004 Nov; 88(2):104-7. PubMed ID: 15499598 [TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Kakar S; Muir T; Murphy LM; Lloyd RV; Burgart LJ Am J Clin Pathol; 2003 Mar; 119(3):361-6. PubMed ID: 12645337 [TBL] [Abstract][Full Text] [Related]
9. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma. Hanif R; Mansoor S J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115 [TBL] [Abstract][Full Text] [Related]
10. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis]. Tátrai P Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466 [TBL] [Abstract][Full Text] [Related]
11. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma. Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797 [TBL] [Abstract][Full Text] [Related]
12. Metastatic hepatocellular carcinoma of skin diagnosed with hepatocyte paraffin 1 and a-fetoprotein immunostainings. Terada T; Sugiura M Int J Surg Pathol; 2010 Oct; 18(5):433-6. PubMed ID: 18499685 [TBL] [Abstract][Full Text] [Related]
13. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Wieczorek TJ; Pinkus JL; Glickman JN; Pinkus GS Am J Clin Pathol; 2002 Dec; 118(6):911-21. PubMed ID: 12472285 [TBL] [Abstract][Full Text] [Related]
14. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms. Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287 [TBL] [Abstract][Full Text] [Related]
15. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA. Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520 [TBL] [Abstract][Full Text] [Related]
16. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma. Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439 [TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma presenting as a precocious cutaneous metastasis. Royer MC; Rush WL; Lupton GP Am J Dermatopathol; 2008 Feb; 30(1):77-80. PubMed ID: 18212552 [TBL] [Abstract][Full Text] [Related]
18. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls. Geramizadeh B; Boub R; Rahsaz M Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119 [TBL] [Abstract][Full Text] [Related]
19. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver. Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122 [TBL] [Abstract][Full Text] [Related]
20. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies. Nassar A; Cohen C; Siddiqui MT Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]